Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

If you're holding shares of Vertex Pharmaceuticals or thinking about adding some to your portfolio, you're not alone in ...

In the latest close session, Vertex Pharmaceuticals (VRTX) was down 1.49% at $414.86. The stock's performance was behind the S&P 500's daily loss of 0.28%. Meanwhile, the Dow lost 0.52%, and the ...

Vertex Pharmaceuticals (VRTX) shares saw mild movement today, with the stock ticking slightly higher over the past week.

Looking at options history for Vertex Pharmaceuticals (NASDAQ: VRTX) we detected 10 trades. If we consider the specifics of ...

William Blair analyst Jake Roberge has maintained their bullish stance on VERX stock, giving a Buy rating today. Jake Roberge has given his Buy rating due to a combination of factors including ...

Bradley Sills, an analyst from Bank of America Securities, reiterated the Hold rating on Vertex (VERX – Research Report). The associated price target was raised to $40.00. Bradley Sills has given his ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Ratings for Vertex (NASDAQ: VERX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and ...